Alys Pharmaceuticals

  • BioTech/Drugs
  • Boston MA
  • 5 employees
Employee Directory Email Format Management Departments
Get Full Info

Company Overview

Website
alyspharma.com
Employees
5
Industry
BioTech/Drugs
More Details

Recent News & Media

Alys Pharmaceuticals Submits ALY-301 Clinical Trial Application in Germany for Cold Urticaria

  • Jun 12, 2025
  • dermatologytimes.com

Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria

  • Jun 10, 2025
  • marketwatch.com

Alys Pharmaceuticals submits CTA for ALY-301 for cold urticaria

  • Jun 10, 2025
  • bioworld.com

Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals

  • May 9, 2025
  • umassmed.edu

Young Vitiligo Patients Face Hurdles to UVB Therapy

  • Mar 31, 2025
  • medscape.com

Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata

  • Mar 27, 2025
  • prnewswire.com

Who is Alys Pharmaceuticals

Alys Pharmaceuticals is a biotechnology company based in Boston, Massachusetts. Founded in February 2024, Alys is a relatively small company with five employees. Alys Pharmaceuticals specializes in immuno-dermatology, focusing on developing innovative treatments for a range of skin conditions. Their pipeline includes programs and platforms targeting multiple dermatological indications. The company aims to address significant unmet medical needs in dermatology and transform the treatment paradigms for prevalent skin diseases. Alys Pharmaceuticals emerged from the consolidation of six asset-centric companies under the Medixci umbrella. This integration has resulted in a robust portfolio of assets and platforms, acquired from companies like Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences, and Vimela Therapeutics. To learn more about Alys Pharmaceuticals and their innovative research, visit their website at alyspharma.com.

Company Leadership

Lars French

Acting Chief Medical Officer

Phone Email

Companies Similar to Alys Pharmaceuticals

Analyze industry trends and opportunities by examining competitors and companies comparable to Alys Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in

22nd Century Group

 Buffalo, NY

GeneAlign LLC

 4 Chandler, AZ 2014

Medicina Natural

 6 Fort Worth, TX

Regenerative Biologics Inc

 23 Gainesville, FL

Serinity Spa

 4 Marietta, GA
View More Companies

FAQ

What is the location of Alys Pharmaceuticals's headquarters?
The headquarters of Alys Pharmaceuticals are situated at 100 Northern Avenue, Boston MA
What is Alys Pharmaceuticals's official website?
The official website of Alys Pharmaceuticals can be found at alyspharma.com.
How many employees does Alys Pharmaceuticals currently have?
Alys Pharmaceuticals employs approximately 5+ people as of February 2024
Which industries is Alys Pharmaceuticals primarily operating in?
Alys Pharmaceuticals operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the Acting Chief Medical Officer of Alys Pharmaceuticals?
Alys Pharmaceuticals's Acting Chief Medical Officer is Lars French

Employee Directory

Key Employees

Mark Prausnitz

Co-Founder

Phone Email

Thibaud Portal

Chief Operating Officer

Phone Email